- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Dixie L. Johnson
Events 15 results
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Speaking Engagement
November 2, 2021
Craig Carpenito, Dixie Johnson, Nikki Reeves, Seth Lundy to Speak at Virtual 22nd Annual Pharmaceutical and Medical Device Ethics and Compliance Congress
Speaking Engagement
January 25, 2021
Dixie Johnson, Richard Walker to Speak on 2021 Securities Regulation Institute’s Virtual Conference
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Speaking Engagement
November 6, 2020
Dixie Johnson, Richard Walker to Speak on Live Webcast of PLI’s 52nd Annual Institute on Securities Regulations
Speaking Engagement
October 28, 2020
Dixie Johnson, Dick Walker to Speak at Securities Enforcement Forum 2020
Speaking Engagement
May 29, 2020
Dixie Johnson to Speak at PLI’s Enforcement 2020: Perspectives from Government Agencies
Speaking Engagement
January 29, 2020
Dixie Johnson, Sally Yates to Speak at 46th Annual Securities Regulation Institute
Conference
November 12, 2019
12th Annual King & Spalding Pharmaceutical University
Speaking Engagement
November 4, 2019
Dixie Johnson to Speak at PLI’s 51st Annual Institute on Securities Regulation
Speaking Engagement
November 4, 2019
Dick Walker, Carmen Lawrence, Dixie Johnson to Speak at Practising Law Institute’s 51st Annual Institute on Securities Regulation
Speaking Engagement
October 23, 2019
Dixie Johnson to Speak at Securities Enforcement Forum 2019